Brian Henick, MD

Specialties:
Hematology/Oncology, Internal Medicine

More specialties
Accepting New Patients

Virtual Visits/Telehealth

Profile Navigation

Overview
Schedule an Appointment
Location(s)
Insurance Accepted
Credentials & Experience
Research

Overview

Dr. Henick is a medical oncologist specializing in the care of patients with malignancies of the aerodigestive tract.?As the Associate Director of Experimental Therapeutics and Director of Translational Research in Aerodigestive Cancers in Medical Oncology, Dr. Henick’s clinical care and research are aligned to improve the effectiveness of, and limit toxicity from, emerging cancer treatments. These efforts?entail clinical trials that Dr. Henick has written and leads to study novel therapeutic approaches and to reduce steroid dependence among patients experiencing adverse events from?immunotherapy.?

Areas of Expertise / Conditions Treated

Esophageal Cancer
Immunotherapy
Lung Cancer
Mesothelioma
Thoracic Cancer
Thoracic Lung Cases
Thoracic Oncology
Thymoma

Academic Appointments

Assistant Professor of Medicine at CUMC

Administrative Titles

Associate Director, Experimental Therapeutics
Director of Translational Research, Upper Aerodigestive Cancers in Medical Oncology

Hospital Affiliations

NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

Male

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.
Schedule Virtual Visit

Phone Appointments

Existing Patients: (212) 305-3997


New Patients: (212) 305-5098

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.
Connect Sign In

Location(s)

CUIMC/Herbert Irving Pavilion
161 Fort Washington Avenue

New York, NY 10032





Open location in Google Maps

Insurance Accepted

Aetna

Aetna Signature Administrators
EPO
HMO
Medicare Managed Care
NYP Employee Plan
NY Signature
POS
PPO
Student Health

Affinity Health Plan

Essential Plan
Medicaid Managed Care

AgeWell

Medicare Managed Care
Special Needs

Amida Care

Special Needs

Cigna

EPO
Great West (National)
HMO
POS
PPO

Emblem/GHI

Medicare Managed Care
PPO

Emblem/HIP

ConnectiCare
EPO
Essential Plan
HMO
Medicaid Managed Care
Medicare Managed Care
POS
PPO
Select Care (Exchange)
Vytra

Empire Blue Cross/Blue Shield

EPO
HMO
Medicare Managed Care
PPO

Empire Blue Cross Blue Shield HealthPlus

Child/Family Health Plus
Essential Plan
Medicaid Managed Care

Fidelis Care

Child/Family Health Plus
Essential Plan
Medicaid Managed Care
Medicare Managed Care

Healthfirst

Child/Family Health Plus
Leaf (Exchange)
Medicaid Managed Care
Medicare Managed Care

Local 1199

Local 1199

MagnaCare (National)

MagnaCare

Medicare

Railroad
Traditional Medicare

Multiplan

Multiplan

MVP Health Care

Child/Family Health Plus
Essential Plan
HMO
Medicaid Managed Care

Oxford Health Plans

Freedom
Liberty

RiverSpring

Special Needs

UnitedHealthcare

Compass (Exchange)
Empire Plan
HMO
Medicaid (Community Plan)
Medicare Managed Care
POS
PPO

VNSNY CHOICE

Medicare Managed Care
SelectHealth
Special Needs

WellCare

Medicaid Managed Care
Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

New Jersey Medical School
Internship: Yale New Haven Hospital
Residency: Yale New Haven Hospital
Fellowship: Yale New Haven Hospital

Board Certifications

Internal Medicine

Honors & Awards

Gold Humanism Honor Society (2011)
CCF/ASCO Young Investigator Award (2017)
SITC Sparkathon (2017-18)
CCF/ASCO Merit Award (2018)
ASCO Journals Editorial Fellowship (2018)

Research

Collaborating with several laboratories at the HICCC (especially Dr. Hiroshi Nakagawa, Dr. Steven Reiner and Dr. Anil K. Rustgi), Dr. Henick is developing personalized blood- and imaging-based biomarkers to guide precision cancer therapy, and to leverage cutting-edge model systems to test and enhance novel treatment approaches. Dr. Henick has presented his work at national conferences such as ASCO, and his accolades include induction to the Gold Humanism Honor Society, research awards from the EGFR Resisters and Conquer Cancer Foundation/ASCO, and selection to the SITC Sparkathon and IASLC Academy. He was a Top Reviewer for the Journal of Clinical Oncology, Precision Oncology, where he was the inaugural Editorial Fellow and currently serves on the editorial board.
A “Minority/Underserved-NCORP Champion”, Dr. Henick is committed to enhancing representation of underserved minority groups in our clinical trials to help assure that all patients may benefit from the results of his research. He will be Columbia’s site lead for an upcoming NYC-wide effort to study the effects of immunotherapy in underserved minority patients with lung cancer.